This is a mechanism module, not a specific disease. Disorder entries should reference individual nodes via conforms_to using "synaptic_vesicle_cycle#<Node Name>"; the key conformance target is "synaptic_vesicle_cycle#Impaired Calcium-Triggered SNARE-Mediated Vesicle Fusion", the central integrating step of the release machine. The generic cell type is neuron (CL:0000540); conforming entries substitute the disease-relevant subtype (e.g. cortical glutamatergic neuron, GABAergic interneuron, spinal motor neuron at the neuromuscular junction). This module is deliberately presynaptic and complementary to — not a duplicate of — the postsynaptic excitatory_synapse_scaffold_disruption module (PSD scaffold genes such as SHANK3 and SYNGAP1), the network-level epilepsy_excitation_inhibition_imbalance module (which models hyper-synchronous firing rather than the presynaptic release lesion), and the glutamate_excitotoxicity module (receptor-overactivation cell death). The clinical convergence (which specific DEE syndrome, presynaptic myasthenia, or movement disorder results) is disorder-specific and stays on the conforming disorder entries. Module evidence reuses PMIDs that are curated and cached in the conforming disorder entries and in the foundational synaptic-vesicle-cycle and SNAREopathy literature; it is illustrative of the abstracted pattern rather than an exhaustive citation set. Worked conformers span the cycle's arms: SYN1-related disorder (vesicle clustering / reserve pool), STXBP1 encephalopathy and UNC13A congenital NDD (docking/priming), SYT1-associated neurodevelopmental disorder / Baker-Gordon syndrome (the calcium-sensor arm) with the three core SNARE-subunit disorders SNAP25 and STX1B (t-SNAREs) and VAMP2 (v-SNARE) and the SNARE-regulator/fusion-clamp disorder CPLX1, and DNM1 encephalopathy (the endocytosis/recycling arm). These are collected as the Synaptic_Vesicle_Cycle_Disorders grouping.
Synaptic Vesicle Cycle Protein Deficiency
trigger
The proximal molecular lesion: loss of function or dysregulation of a presynaptic protein that acts at one of the steps of the synaptic vesicle cycle (neurotransmitter loading, vesicle clustering, docking, priming, Ca2+-triggered fusion, or endocytic recycling). Because these proteins operate as a single integrated release machine, a defect in any one component reduces or dysregulates neurotransmitter release. Conforming entries substitute the disease gene and the specific cycle step it disrupts.
Downstream
-
Impaired Vesicle Docking and Priming
Loss of a docking/priming factor (Munc18-1, Munc13, RIM) prevents assembly of release-ready vesicles at the active zone.
-
Impaired Calcium-Triggered SNARE-Mediated Vesicle Fusion
Loss of a SNARE, the Ca2+ sensor, or its regulators directly impairs the membrane-fusion step.
-
Impaired Synaptic Vesicle Endocytosis and Recycling
Loss of an endocytic factor (dynamin-1, synaptojanin-1) impairs retrieval and regeneration of release-ready vesicles.
Show evidence (3 references)
"To support rapid and repeated rounds of release, synaptic vesicles undergo a trafficking cycle."
Establishes the synaptic vesicle trafficking cycle as the conserved presynaptic process whose component proteins are the substrate of this module.
"Human pathogenic mutations have now been reported for all eight core components, but patients are diagnosed with very different neurodevelopmental syndromes."
Documents that pathogenic mutations across the core release machinery cause a family of neurodevelopmental disorders, the disease scope of this module.
"Strikingly, 75% of mutations in these probands are predicted to disrupt a protein involved in regulating synaptic transmission"
A large epileptic-encephalopathy cohort finds that most causal de novo mutations disrupt synaptic-transmission proteins, supporting the presynaptic release machinery as a convergent disease pathway.
Impaired Vesicle Docking and Priming
upstream
Synaptic vesicles are tethered at the presynaptic active zone and rendered fusion-competent (primed) by a dedicated set of proteins — the Sec1/Munc18 protein Munc18-1 (STXBP1), the priming factor Munc13 (UNC13A), and the active-zone scaffold RIM (RIMS1). Munc18-1 chaperones syntaxin-1 and templates SNARE-complex assembly, so its loss abolishes neurotransmitter secretion. Failure of docking/priming depletes the readily releasable vesicle pool and reduces release probability upstream of fusion.
Downstream
-
Impaired Calcium-Triggered SNARE-Mediated Vesicle Fusion
Without docked, primed vesicles and correctly chaperoned syntaxin-1, the SNARE-mediated fusion step cannot proceed.
Show evidence (2 references)
"Recycling then leads to the docking and priming of the vesicles for another round of exo- and endocytosis."
Establishes docking and priming as the vesicle-cycle step that generates fusion-competent vesicles, the process disrupted at this node.
"Deletion of a single protein, Munc18-1, in mice leads to a complete loss of neurotransmitter secretion from synaptic vesicles throughout development."
The Munc18-1 (STXBP1) null mouse shows that loss of this docking/priming protein abolishes neurotransmitter secretion, the mechanistic anchor of the node.
Impaired Synaptic Vesicle Endocytosis and Recycling
upstream
After exocytosis, vesicle membrane and proteins are retrieved by endocytosis and recycled to regenerate release-ready vesicles, sustaining transmission during repeated firing. Dynamin-1 (DNM1) mediates the fission of endocytosing vesicles and synaptojanin-1 (SYNJ1) the phosphoinositide-dependent uncoating step. Failure of endocytic recycling depletes the recycling vesicle pool and causes activity-dependent synaptic-transmission failure, feeding back on the fusion step by starving it of vesicles.
Downstream
-
Impaired Calcium-Triggered SNARE-Mediated Vesicle Fusion
Depletion of the recycling vesicle pool starves the fusion step of release-ready vesicles during sustained activity.
-
Neurotransmitter Release Failure and Synaptic Transmission Deficit
Failure to regenerate vesicles causes activity-dependent synaptic transmission failure.
Show evidence (2 references)
"The focal point of the vesicle cycle is Ca2+-triggered exocytosis that is followed by different routes of endocytosis and recycling."
Establishes endocytosis and recycling as the vesicle-cycle steps that regenerate release-ready vesicles, the process disrupted at this node.
"We bring statistical evidence that mutations in DNM1 cause epileptic encephalopathy"
Establishes DNM1 (dynamin-1, the vesicle-endocytosis fission GTPase) as a cause of epileptic encephalopathy, anchoring the endocytosis/recycling node to human disease.
Neurotransmitter Release Failure and Synaptic Transmission Deficit
effector
The convergent endpoint: reduced or dysregulated Ca2+-evoked neurotransmitter release impairs chemical synaptic transmission across the affected synapse population. Depending on the neurons involved this manifests as a developmental and epileptic encephalopathy (cortical excitatory/inhibitory imbalance), a presynaptic congenital myasthenic syndrome (motor-nerve-terminal transmission failure at the neuromuscular junction), and/or a movement disorder. This is the shared clinical-mechanistic endpoint; the specific syndrome is disorder-specific and stays on the conforming disorder entries.
Show evidence (2 references)
"Deletion of a single protein, Munc18-1, in mice leads to a complete loss of neurotransmitter secretion from synaptic vesicles throughout development."
Demonstrates that loss of a single vesicle-cycle protein produces the convergent endpoint of failed neurotransmitter secretion.
"We argue that disease severity generally scales with functional redundancy"
Explains why the shared release-failure endpoint yields graded clinical severity across the different vesicle-cycle genes, supporting a common convergent mechanism with disorder-specific manifestations.